The evolution of sample management and automation in drug discovery

Drug discovery has traditionally relied on high-throughput screening of small molecules, necessitating the storage, management, and testing of vast compound libraries In this case study, Azenta interviewed Sue Holland-Crimmin, a veteran of the pharmaceutical industry and expert in drug discovery. She discussed the lessons learned in drug development and how pharma/biotech companies can address key challenges that impact creating more efficient workflows.